Cyanocobalamin tablets 50mcg
- Minimum Order Quantity
- 1000 Pack
- Price Or Price Range
- Formulations Type
- General Drugs
- Formulations Form
- Treatments & Functions
- Treatment of nutritional Vitamin B12 deficiency. Treatment of vitamin B 12 deficiency following partial gastrectomy. Treatment of tropical sprue, alone or with folic acid. Treatment of pernicious anaemia when parenteral administration is not possible or not advised
- Storage Instructions
- Dry Place
Product name: Cyanocobalamin tablets 50mcg
Cyanocobalamin 50micrograms Tablets
Qualitative and quantitative composition
Each tablet contains 50 micrograms Cyanocobalamin BP.
Recommended Clinical Indications:
Treatment of nutritional Vitamin B12 deficiency.
Treatment of vitamin B 12 deficiency following partial gastrectomy.
Treatment of tropical sprue, alone or with folic acid.
Treatment of pernicious anaemia when parenteral administration is not possible or not advised.
Adults: - One to three tablets (50 to 150 micrograms) or more daily at the discretion of the physician.
In pernicious anaemia intramuscular therapy is preferable for initial correction of vitamin B12 deficiency. However, if necessary, the oral route may be used to follow this, in which case at least 300 micrograms should be given daily.
Elderly: - The normal dose for adults is appropriate for the elderly.
Children: - One tablet (50 micrograms) daily at the discretion of the physician.
When possible,This medicine doses should be taken between meals.
Method of administration: Oral.
Hypersensitivity to the product or any of the excipients.
Special warnings and precautions for use
For pernicious anaemia, an adequate dose must be used and the blood picture must be examined regularly at least every three months for 18 months until stabilised, and then annually.
Indiscriminate administration of this medicine may mask precise diagnosis.
Interaction with other medicinal products and other forms of interaction
Absorption may be reduced by Para-aminosalicylic acid, colchinine, biguanides, neomycin, cholestyramine, potassium chloride, methyldopa, and cimetidine.
Patients treated with may respond poorly to this medicine .
Serum levels of this medicine may be lowered by oral contraceptives. These interactions are unlikely to have clinical significance.
Anti-metabolities and most antibiotics invalidate vitamins B12 assays by microbiological techniques.
Pregnancy and lactation
This medicine should not be used to treat megaloblastic anaemia of pregnancy because this is due to folate deficiency.
Sensitisation to this medicine is rare, but may present as an itching exanthema, and exceptionally as anaphylactic shock.
Acneform and bullous eruptions have been reported rarely.
Patients who have become sensitised to this medicine by injection are often able to tolerate the oral route without trouble.
Overdosage is unlikely to require treatment.
This medicine contain cyanocobalamin vitamin B 12, which is used for the treatment of pernicious anaemia, and nutritional deficiencies of vitamin B 12 which results in macrocytic anaemia.
The absorption of cobalamins from the gut is dependent upon the glycoprotein intrinsic factor. Cobalamins are transported rapidly into the blood bound to protein, known as transcobalamins. Cobalamins are stored in the liver and excreted in the bile.
Preclinical safety data
No further relevant data.
List of excipients
Maize Starch BP
Magnesium Stearate BP
Purified Water BP
Hydroxypropyl Methylcellulose 2910 Ph.Eur
Ethylcellulose Ph Eur
Speed colour White 27120 Ansteads HSE (Titanium dioxide, talc and polysorbate)
Isopropyl Alcohol BP
36 months in securitaners
24 months in blisters
Special precautions for storage
Protect from light.
Store in well closed containers.
Store below 25°C, protected from light.
Packaging customize as per customer requirements.
- Delivery Time
- 30 Days
- Packaging Details
- Customize as per customer requirements